Salazar, Marissa .
HRN: 24-02-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2023
CEFUROXIME 500MG (TAB)
11/04/2023
11/11/2023
PO
500mg
BID
IUFD; UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes